NCT05042505View on ClinicalTrials.gov

Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus and Liver Transplantation

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 5, 2024

Study Completion Date

November 1, 2025

Conditions
Diabetes MellitusLiver Transplant; Complications
Interventions
DRUG

Dapagliflozin 10Mg Tab

Dapa group (n = 50): Patients with diabetes mellitus will receive Dapagliflozin 10 mg

DRUG

Sitagliptin 100mg

Sita group (n = 50): Patients with diabetes mellitus will receive sitagliptin 100 mg once daily

Trial Locations (1)

122001

RECRUITING

Division Of Endocrinology & Diabetes, Medanta The Medicity, Gurgaon

All Listed Sponsors
lead

Medanta, The Medicity, India

OTHER